Osteoporosis prevalence and levels of treatment in primary care: The Australian bonecare study

Journal of Bone and Mineral Research

Volumn 19, Issue 12, 2004, Pages 1969-1975

  Eisman, John ^a   Clapham, Sharon ^b,d   Kehoe, Linda ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Merck Sharp and Dohme (Australia)   (Australia)

^c TOTAL   (France)

^d Merck Sharp and Dohme Australia ^*  (Australia)

Author keywords

Diagnosis; Osteoporosis; Prevalence; Primary care; Recognition; Treatment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID;

ADULT; AGE DISTRIBUTION; ARTICLE; BACKACHE; BODY WEIGHT; CALCIUM INTAKE; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; EARLY MENOPAUSE; FAMILY HISTORY; FEMALE; FRAGILITY FRACTURE; HUMAN; KYPHOSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; VERTEBRA FRACTURE; AGE; AGED; AUSTRALIA; BODY HEIGHT; BONE DENSITY; FRACTURE; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK; SPINE FRACTURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AUSTRALIA; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; CALCIUM; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; SPINAL FRACTURES;

EID: 18744389111     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.040905     Document Type: Article

References (31)

1. Eastell R 1998 Drug therapy: Treatment of postmenopausal osteoporosis. N Engl J Med 338:736-746.
2. Hofman A, Grobbee DE, De Jong PTVM, Van Den Ouweland FA 1991 Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7:403-422.
3. Mosekilde L, Hermann AP, Beck-Nielsen H, Charles P, Nielsen SP, Sorensen OH 1999 Danish Osteoporosis Prevention Study (DOPS): Project design and inclusion of 2000 normal perimenopausal women. Maturitas 31:207-219.
4. Sanders KM, Nicholson GC, Ugoni AM, Pasco JA, Seeman E, Kotowicz MA 1999 Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study. Med J Australia 170:467-470.
5. Sanders KM, Seeman E, Ugoni AM, Paxco JA, Martin TJ, Skoric B, Nicholson GC, Kotowicz MA 1999 Age- and gender-specific rate of fractures in Australia: A population-based study. Osteoporos Int 10:240-247.
6. Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C, Eisman JA 1994 Symptomatic fracture incidence in elderly men and women: The Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 4:277-282.
7. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III 1992 Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 7:221-227.
8. Cooper C 1997 The crippling consequences of fractures and their impact on quality of life. Am J Med 103:12S-19S.
9. Center JR, Nguyen TV, Schneider D, Sambrook PH, Eisman JA 1999 Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet 353:878-882.
10. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group. Lancet 348:1535-1541.
11. Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Conner E, Musliner T, Thompson D 1999 Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum 42:1246-1254.
12. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437-1443.
13. Chestnut CH III, Silverman S, Andriano K, Genant H, Gimona A, Harris S, Kiel D, LeBoff M, Maricic M, Miller P, Moniz C, Peacock M, Richardson P, Watts N, Baylink D 2000 A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 109:267-276.
14. Pols HAP, Felsenberg D, Hanley DA, Stepan J, Munoz-Torres M, Wilkin TJ, Qin-Sheng G, Galich AM, Vandormael K, Yates AJ, Stych B 1999 Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study. Osteoporos Int 9:461-468.
15. Tilyard MW, Spears GF, Thomson J, Dovey S 1992 Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357-362.
16. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ 1994 Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308:1081-1082.
17. Dawson-Hughes B, Harris SS, Drall EA, Dallal GE 1997 Effect of calcium and vitamin D suppementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676.
18. Overgaard K, Hansen MA, Jensen SB, Christiansen C 1992 Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: A done-response study. BMJ 305:556-561.
19. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ 1993 The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329:1141-1146.
20. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR 1995 Estrogen replacement therapy and fractures in older women: Study of Osteoporotic Fractures Research Group. Ann Intern Med 122:9-16.
21. Cummings SR 1998 Prevention of hip fractures in older women: A population-based perspective. Osteoporos Int 8:S8-S12.
22. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi Eis S, Gennari C, Johnell O, Johnston CC Jr, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N 1999 Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 10:259-264.
23. Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, Seeman E, Wasnich RD 1999 Diagnosis and management of osteoporosis in postmenopausal women: Clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther 21:1025-1044.
24. Epstein S, Goodman GR 1999 Improved strategies for diagnosis and treatment of osteoporosis. Menopause 6:242-250.
25. Epstein RS, Feng W, Hirsch LJ, Kelly M 1998 Intervention thresholds for the treatment of osteoporosis: Comparison of different approaches to decision making. Osteoporos Int 8:S22-S27.
26. Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH 2003 Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163:2052-2057.
27. Nevitt MC, Cummings SR, Browner WS, Seeley DG, Cauley JA, Vogt TM, Black DM 1992 The accuracy of self-report of fractures in elderly women: Evidence from a prospective study. Am J Epidemiol 135:290-299.
28. Ismail AA, O'Neill TW, Cockerill W, Finn JD, Cannata JB, Hoszowski K, Johnell O, Matthis C, Raspe H, Raspe A, Reeve J, Silman AJ, the EPOS Study group 2000 Validity of self-report of fractures: Results from a prospective study in men and women across Europe. Osteoporos Int 11:248-254.
29. Ismail AA, Cooper C, Felsenberg D, Varlow J, Kanis JA, Silman AJ, O'Neill TW 1999 Number and type of vertebral deformities: Epidemiological characteristics and relation to back pain and height loss. Osteroporos Int 9:206-213.
30. Wei GS, Jackson JL, Herbers JE Jr 2003 Ethnic disparity in the treatment of women with established low bone mass. J Am Med Womens Assoc 58:173-177.
31. Mudano AS, Casebeer L, Patino F, Allison JJ, Weissman NW, Kiefe CI, Person S, Gilbert D, Saag KG 2003 Racial disparities in osteoporosis prevention in a managed care population. South Med J 96:445-451.